Hauptseite > Publikationsdatenbank > New developments in the production of theranostic pairs of radionuclides > print

001     858324
005     20220930130203.0
024 7 _ |a 10.1007/s10967-018-6238-x
|2 doi
024 7 _ |a 0022-4081
|2 ISSN
024 7 _ |a 0134-0719
|2 ISSN
024 7 _ |a 0236-5731
|2 ISSN
024 7 _ |a 1417-2097
|2 ISSN
024 7 _ |a 1588-2780
|2 ISSN
024 7 _ |a 2064-2857
|2 ISSN
024 7 _ |a 2128/20568
|2 Handle
024 7 _ |a WOS:000451746300005
|2 WOS
037 _ _ |a FZJ-2018-07212
082 _ _ |a 540
100 1 _ |a Qaim, Syed M.
|0 P:(DE-Juel1)131840
|b 0
|e Corresponding author
245 _ _ |a New developments in the production of theranostic pairs of radionuclides
260 _ _ |a Dordrecht [u.a.]
|c 2018
|b Springer Science + Business Media B.V
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1579269519_3220
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a A brief historical background of the development of the theranostic approach in nuclear medicine is given and seven theranostic pairs of radionuclides, namely 44gSc/47Sc, 64Cu/67Cu, 83Sr/89Sr, 86Y/90Y, 124I/131I, 152Tb/161Tb and 152Tb/149Tb, are considered. The first six pairs consist of a positron and a β−-emitter whereas the seventh pair consists of a positron and an α-particle emitter. The decay properties of all those radionuclides are briefly mentioned and their production methodologies are discussed. The positron emitters 64Cu, 86Y and 124I are commonly produced in sufficient quantities via the (p,n) reaction on the respective highly enriched target isotope. A clinical scale production of the positron emitter 44gSc has been achieved via the generator route as well as via the (p,n) reaction, but further development work is necessary. The positron emitters 83Sr and 152Tb are under development. Among the therapeutic radionuclides, 89Sr, 90Y and 131I are commercially available and 161Tb can also be produced in sufficient quantity at a nuclear reactor. Great efforts are presently underway to produce 47Sc and 67Cu via neutron, photon and charged particle induced reactions. The radionuclide 149Tb is unique because it is an α-particle emitter. The present method of production of 152Tb and 149Tb involves the use of the spallation process in combination with an on-line mass separator. The role of some emerging irradiation facilities in the production of special radionuclides is discussed.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Scholten, Bernhard
|0 P:(DE-Juel1)131846
|b 1
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 2
773 _ _ |a 10.1007/s10967-018-6238-x
|g Vol. 318, no. 3, p. 1493 - 1509
|0 PERI:(DE-600)2017242-4
|n 3
|p 1493 - 1509
|t Journal of radioanalytical and nuclear chemistry
|v 318
|y 2018
|x 1588-2780
856 4 _ |u https://juser.fz-juelich.de/record/858324/files/Qaim2018_Article_NewDevelopmentsInTheProduction.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/858324/files/qaim_2936129498.pdf
856 4 _ |u https://juser.fz-juelich.de/record/858324/files/Qaim2018_Article_NewDevelopmentsInTheProduction.pdf?subformat=pdfa
|x pdfa
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/858324/files/Autorenmanuskript.pdf
|y Published on 2018-10-19. Available in OpenAccess from 2019-10-19.
|z StatID:(DE-HGF)0510
856 4 _ |u https://juser.fz-juelich.de/record/858324/files/Autorenmanuskript.pdf?subformat=pdfa
|x pdfa
|y Published on 2018-10-19. Available in OpenAccess from 2019-10-19.
|z StatID:(DE-HGF)0510
856 4 _ |u https://juser.fz-juelich.de/record/858324/files/qaim_2936129498.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:juser.fz-juelich.de:858324
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131840
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131846
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J RADIOANAL NUCL CH : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a APC
980 _ _ |a UNRESTRICTED
980 1 _ |a APC
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21